Evidence map›Paper›PMID 42405870›Full record

ArticleGenetics2026

Creation and manipulation of bipartite expression transgenes in C. elegans using phiC31 recombinase.

Michael L Nonet

Abstract read
In one paragraph

Article in Genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Modular gene tagging inResearch square · 2026
    Article
  5. Modular gene tagging inbioRxiv : the preprint server for biology · 2026
    Article
  6. High-efficiency targeted integration of extrachromosomal arrays inbioRxiv : the preprint server for biology · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michael L NonetDepartment of Neuroscience, School of Medicine, Washington University in St.Louis, 660 South Euclid Avenue, St. Louis, MO 63110, United States.

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
Novel transgenesis and expression technology for nematodesR01GM141688 · NIGMS · WASHINGTON UNIVERSITY · PI NONET, MICHAEL L · 2021 to 2023
$818k
NIGMS NIH HHS R01 GM141688NIH HHS P40 OD010440NIH HHS R01GM141688
6 · The paper itself

Abstract

Bipartite expression systems are widely used in model organisms to express specific gene products in a cell-specific context. They are typically encoded as 2 independent, unlinked transgenic insertions: a driver and a reporter. Herein, I outline an efficient method named recombination-mediated homolog exchange that uses genetically encoded phiC31 recombinase to convert driver and reporter transgenes integrated at the same genetic position from a trans configuration, where 1 component is on each chromosome, to a cis configuration where the driver and reporter are on the same chromosome. This approach is based upon the development of a set of 3' attB-tagged driver lines and 5' attP-tagged reporter lines. This genetic-based approach leverages both the power of combinatorial re-assortment of drivers and reporters and the simplicity of single locus genetics. I also describe a novel microinjection-based approach named recombination-mediated integration that utilizes the individual attB driver and attP reporter lines as landing sites for the phiC31 recombinase-mediated integration of whole driver and reporter plasmids into the existing reporter and driver lines, respectively. These new tools increase the utility of bipartite systems for C. elegans genetics by reducing the complexity of reporter system segregation in crosses and thus can greatly simplify their use in genetic analysis. These new methods are not limited to manipulating bipartite systems and can be equally utilized for the manipulation and creation of other transgenes.

Indexed as

Caenorhabditis elegansDNA NucleotidyltransferasesRecombinasesTransgenesAnimalsAnimals, Genetically ModifiedGenes, ReporterRecombination, GeneticDNA NucleotidyltransferasesRecombinasesFLP recombinaseplasmid integrationpromoter crosstalkRMCEWormBase

Identifiers

PMID42405870
PMCPMC13535217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.